Home/Filings/4/0001104659-24-077835
4//SEC Filing

McCarthy Reid 4

Accession 0001104659-24-077835

CIK 0001477845other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 5:17 PM ET

Size

5.8 KB

Accession

0001104659-24-077835

Insider Transaction Report

Form 4
Period: 2023-11-17
Transactions
  • Award

    Stock Option (right to buy)

    2023-11-17+29,60029,600 total
    Exercise: $6.07Exp: 2033-11-17Common Stock (29,600 underlying)
Footnotes (2)
  • [F1]On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved.
  • [F2]The stock option shall vest immediately upon grant date.

Issuer

Annovis Bio, Inc.

CIK 0001477845

Entity typeother

Related Parties

1
  • filerCIK 0001857733

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:17 PM ET
Size
5.8 KB